Histopathology is the examination of diseased or abnormal tissues using microscopic and related techniques to identify structural changes and establish diagnoses. It is a major component of anatomical pathology and is particularly important in cancer diagnosis, where tissue architecture and cellular morphology can determine tumour type, grade and other clinically relevant characteristics. Tissue is commonly obtained through biopsy or surgical excision and undergoes fixation, processing, embedding, sectioning and staining before microscopic examination. Histopathology allows pathologists to assess the relationship between cells and tissues rather than examining isolated biomarkers alone. It therefore provides morphological evidence that can integrate with clinical, imaging and molecular findings.
The standard histopathological process begins with obtaining a representative tissue specimen. Fixation preserves tissue structure and prevents decomposition, with formalin based fixation commonly used for many routine specimens. The tissue is then processed to remove water and prepare it for embedding, often in paraffin wax. Thin sections are cut using a microtome, mounted on slides and stained.
Haematoxylin and eosin staining is the fundamental routine stain, with haematoxylin highlighting nuclear material and eosin providing contrast to many cytoplasmic and extracellular components. Additional stains can demonstrate particular substances or structures. Accurate specimen orientation, adequate sampling and preservation are critical because diagnostic conclusions depend on what tissue is actually represented in the section.
Histopathological diagnosis depends on recognising patterns of cellular and tissue abnormality. Pathologists evaluate features such as cellular size and shape, nuclear characteristics, tissue architecture, differentiation, necrosis, inflammation, invasion and relationships with surrounding structures. In cancer, malignancy may be supported by findings such as destructive invasion, abnormal architecture and cytological atypia, although interpretation varies according to tumour type. Tumour grading assesses defined morphological characteristics associated with biological behaviour, while staging concerns the anatomical extent of disease and is distinct from grading. Histopathology can also identify non-neoplastic conditions such as infections, inflammatory diseases, immune disorders, degenerative processes and tissue responses to injury.
Immunohistochemistry is an important extension of Histopathology. It uses antibodies to detect specific proteins within tissue sections and can help distinguish between tumour types, identify tissue lineage or determine whether a clinically relevant protein is expressed. Interpretation depends on staining intensity, distribution, cellular localisation and appropriate controls. Immunohistochemical markers are generally interpreted as panels rather than isolated tests because many proteins are not completely specific for one disease. Molecular tests may be performed on the same specimen when genetic alterations are needed for classification or treatment selection. Modern pathology therefore integrates morphology, immunophenotype and molecular information rather than treating these approaches as independent disciplines.
Histopathology has particular importance in cancer diagnosis because tissue morphology can determine whether a lesion is benign, malignant or indeterminate and can often establish the specific tumour category. A biopsy may also reveal features affecting treatment, such as differentiation, invasion, vascular involvement, perineural invasion or other prognostic characteristics. Resection specimens allow assessment of tumour size, margins, regional lymph nodes and relationships with surrounding structures. Adequate sampling is crucial because heterogeneous tumours may contain areas with different grades or molecular properties. Pathologists must therefore balance thorough examination with efficient use of tissue, particularly when the same specimen is needed for immunohistochemistry and molecular diagnostics.
Histopathological interpretation contains an element of professional judgement because tissue patterns can overlap among different diseases. Pathologists use established classification systems, diagnostic criteria, reference materials and multidisciplinary discussion to improve consistency. Artefacts introduced during collection, fixation, processing or sectioning can mimic disease or obscure important features. Poor orientation, crush damage, cautery effects and inadequate tissue can limit diagnostic confidence. Second opinions or specialist review may be appropriate for rare, complex or clinically consequential diagnoses. Digital pathology can support consultation, archiving and computational image analysis, although validation and quality assurance are necessary before automated systems can be relied upon for clinical diagnosis.
Histopathology has evolved from descriptive microscopy toward integrated pathology. Molecular classification has demonstrated that tumours with similar microscopic appearances can have different biological characteristics, while molecularly similar tumours can sometimes display different morphology depending on tissue context. Modern pathology therefore increasingly combines routine microscopy with immunohistochemistry, cytogenetics, sequencing and other assays. Tissue morphology remains important because molecular findings must be interpreted in the context of the cells and structures from which they originate. The physical location of a molecular alteration within a tissue section can also be clinically informative. This integration supports increasingly precise disease classification and personalised treatment.
A common misconception is that Histopathology simply involves looking at tissue under a microscope. In reality, it is a comprehensive diagnostic discipline involving specimen handling, fixation, processing, staining, morphological interpretation, ancillary testing and clinical correlation. Another misconception is that a molecular test automatically replaces histological examination. In many diseases, molecular information is most meaningful when interpreted alongside morphology. Histopathology remains fundamental because tissue architecture provides information that cannot always be obtained from blood or isolated molecular measurements. Its applications extend beyond cancer to inflammatory, infectious, autoimmune, degenerative and many other diseases, making it a central component of diagnostic medicine.
